| CGRP | Calcitonin gene-related peptide |
| 5-HT | 5-hydroxytryptamine |
| PACAP | Pituitary adenylate cyclase activating polypeptide |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| IV | intravenous |
| CBT | Cognitive Behavioral Therapy |
| nVNS | Non-invasive vagal nerve stimulation |
| TMS | transcranial magnetic stimulation |
| ONS | occipital nerve stimulation |
| SMS | supraorbital transcutaneous stimulation |
| BT-A | botulinum toxin A |
| CYP3A4 | Cytochrome P450 3A4 |
| BCRP | breast cancer resistance protein |
| P-glycoprotein | P-gp |
| TEAEs | treatment-emergent adverse events |
| AEs | adverse events |
| ALT | alanine aminotransferase |
| AST | aspartate aminotransferase |